RE: Is there ANY hope left22 Nov 2020 10:35
Guys let the science do the talking. After successful p3 trials we won’t be able to make enough with the orders coming in. If AZ or another big pharma pick up Syn on a partnership or takeover, they will do all the PR and marketing that we need. You need to remember how small we are compared to them but it is reflected in our MCap so we can’t complain. All I know is when we are selling out of 100k treatments a month then we won’t be anywhere near £1!! Fast forward to Q1/Q2 next year and it will be very exciting. If it stays at £1 till then then I’m not worried. I think everybody need to reassess their timeframes and if you can’t wait get out on the next spike. Can’t really listed to negativity for the next 3 months when the company are working their balls off to get a completed p3 trial. David and Goliath part 2. We all know who won that one!